In Vitro Biology

Whether you’re starting from a unique target or conducting ongoing lead discovery programs, we deliver custom assay development and testing services for the pharmaceutical and biopharmaceutical industries.

You can access our expert services as stand-alone solutions or integrated with our full range of chemistry offerings.

When you partner with us, our team will develop robust, tailored assay solutions to support your drug discovery program and give your project the best chance of success.

Click here to review our Assay Development & Screening capabilities.

Curia employs both innovative and established methodologies to generate comprehensive data that helps move your drug discovery program forward. Using state of the art instrumentation and analysis methods, our team develops practical, predictive, and physiologically relevant assays to meet the unique needs of each discovery program, driving more informed and impactful results.

Click here to review our Cell-Based Assay Development & Testing capabilities

Curia’s DMPK scientists deliver expert solutions for your drug discovery programs. Providing bioanalytical methods development, in vitro ADMET testing and in vivo PK and PD services that span all stages of drug discovery up to candidate selection.

Click here to review our DMPK capabilities

Drug discovery is our passion.

Curia’s multi-disciplinary discovery teams and leadership bring the experience, capabilities, insights and commitment required to drive projects to successful conclusions.

We offer comprehensive solutions tailored to your needs. Whether your interest lies in an enzyme inhibitor, molecular glue, structure-based drug development (SBDD) or an off-shore option for lead optimization (India), Curia has a solution for you.

Using cutting edge technologies and experience, we produce quality recombinant proteins for non-human proof-of-concept studies, as custom assay reagents and to support structural biology programs.

Click here to review our Protein Expression & Analysis capabilities

At Curia, our team of expert protein chemists and structural biologists bring the advanced experience and technology needed to support all your structural biology needs. Partnering with Curia means you’re not just getting a deliverable—you’re accessing the wealth of knowledge that can make a real difference for your program.

Click here to learn more about our Structural Biology capabilities and experience.

Curia scientists provide a range of therapeutic antibody testing using state of the art equipment.

• Antibody – Antigen interaction analysis by Cytiva™ Biacore™ SPR or Carterra® LSA™ platform.
• CDC, ADCC, TDCC, ADCP, Fc-mediated binding and function by Revvity Opera Phenix™ or Opera Phenix™ Plus platform.
• On-target and off-target cytokine and chemokine response assays by Luminex®, Meso Scale Discovery™ or FACS™.
• Bioanalytical methods development and bioanalysis (for antibody or protein biomarker).

Click here to review our Cell-Based Assay Development and Testing capabilities.